Page last updated: 2024-12-05

2,2'-dithiobis(5-nitropyridine)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2'-Dithiobis(5-nitropyridine) (DTNP) is a yellow crystalline solid with a molecular weight of 332.34 g/mol. It is commonly used as a reagent in biochemical research for the detection and quantification of sulfhydryl groups in proteins and other biomolecules. DTNP reacts with sulfhydryl groups to form a colored product, which can be measured spectrophotometrically. The reaction is highly specific for sulfhydryl groups and can be used to determine the number and reactivity of these groups in a molecule. DTNP is also used as a reagent for the study of disulfide bond formation and reduction. The synthesis of DTNP typically involves the reaction of 5-nitropyridine with sulfur monochloride. DTNP is a powerful tool for studying the structure, function, and dynamics of proteins and other biomolecules. Its ability to selectively react with sulfhydryl groups allows researchers to probe the properties of these important functional groups. '
```

2,2'-dithiobis(5-nitropyridine): structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16474
CHEMBL ID120580
SCHEMBL ID25358
MeSH IDM0058381

Synonyms (42)

Synonym
5-nitro-2-(5-nitropyridin-2-yl)disulfanyl-pyridine
AKOS015833310
nsc-677436
nsc 149336
ai3-62509
5,5'-dinitro-2,2'-dipyridyl disulfide
pyridine, 2,2'-dithiobis(5-nitro-
einecs 218-344-7
brn 0305413
nsc-149336
2,2'-dithiobis(5-nitropyridine)
2127-10-8
dtnp
nsc149336
pyridine,2'-dithiobis[5-nitro-
bis(5-nitro-2-pyridyl) disulfide
5,2'-dipyridyl disulfide
5-nitro-2-[(5-nitro-2-pyridyl)disulfanyl]pyridine
nsc677436
inchi=1/c10h6n4o4s2/c15-13(16)7-1-3-9(11-5-7)19-20-10-4-2-8(6-12-10)14(17)18/h1-6
2,2'-dithiobis(5-nitropyridine), 96%
CHEMBL120580
5-nitro-2-[(5-nitropyridin-2-yl)disulfanyl]pyridine
2,2'-dithio-bis(5-nitropyridine)
5-21-02-00066 (beilstein handbook reference)
D2222
1,2-bis(5-nitropyridin-2-yl)disulfane
2,2'-dithiobis(5-nitro-pyridine)
2,2'-disulfanediylbis(5-nitropyridine)
SCHEMBL25358
pyridine, 2,2'-dithiobis[5-nitro-
5-nitro-2-[(5-nitro-2-pyridinyl)disulfanyl]pyridine #
pyridine, 2,2'-dithiobis*5-nitro-
DTXSID00175520
mfcd00006453
AS-63460
J-013966
5,5'-dinitro-2,2'-dithiodipyridine
BP-23824
E78124
2,2 inverted exclamation marka-dithiobis(5-nitropyridine)
2,2'-dithiobis[5-nitropyridine]
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID513586Decrease in TRPC5 C553S mutant S-nitrosylation in HEK cells assessed as inhibition of incorporation of DTNB-2Bio at 30 uM relative to control2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID89802Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
AID513595Activation of TRPV3 in HEK cells assessed as increase in Ca2+ level from extracellular space at 10 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513593Activation of rat TRPV1 expressed in HEK cells assessed as increase in Ca2+ level from extracellular space at 10 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID89654Inhibition of HIV-1 replication in human T-cell by using XTT assay; Inactive1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
AID513601Activation of rat TRPV1 Cys621 mutant expressed in HEK cells assessed as increase in Ca2+ level from extracellular space at 10 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513606Activation of TRPC5 expressed in BAEC expressing dominant negative mutant of TRPC5 assessed as increase in Ca2+ level from extracellular space at 100 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513600Activation of rat TRPV1 Cys616 mutant expressed in HEK cells assessed as increase in Ca2+ level from extracellular space at 10 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513583Induction of TRPC5 S-nitrosylation in chicken DT40 cells assessed as increase in Ca2+ level from extracellular space at 30 uM in presence of PLC-beta inhibitor U731222006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513579Induction of S-nitrosylation of TRPC5 in HEK cells assessed as increase in Ca2+ level from extracellular space at 30 uM in presence of ascorbic acid2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513577Induction of TRPM7 S-nitrosylation in HEK cells assessed as increase in Ca2+ level from extracellular space at 30 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513597Activation of TRPV4 in HEK cells assessed as increase in Ca2+ level from extracellular space at 10 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513581Induction of S-nitrosylation of TRPC5 in HEK cells assessed as increase in Ca2+ level from extracellular space at 30 uM in presence of dithiothreitol2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513607Activation of TRPC5 expressed in BAEC expressing TRPC5 siRNA assessed as increase in Ca2+ level from extracellular space at 100 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513576Induction of TRPM2 S-nitrosylation in HEK cells assessed as increase in Ca2+ level from extracellular space at 30 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513574Induction of S-nitrosylation of TRPC5 in HEK cells assessed as increase in Ca2+ level from extracellular space at 30 uM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID513587Decrease in TRPC5 C558S mutant S-nitrosylation in HEK cells assessed as inhibition of incorporation of DTNB-2Bio at 30 uM relative to control2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's10 (55.56)18.2507
2000's4 (22.22)29.6817
2010's2 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.59 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]